0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
China Alzheimer's Disease Drug Market Report & Forecast 2021-2027
Published Date: August 2021
|
Report Code: QYRE-Auto-1529
Home | Market Reports | Health | Aging & Geriatrics
China Alzheimer s Disease Drug Market Report Forecast 2021 2027

China Alzheimer's Disease Drug Market Report & Forecast 2021-2027

Code: QYRE-Auto-1529
Report
August 2021
93 Pages
QYResearch
Region: North America, Asia-PacificEurope, Central & South AmericaRest of Central & South America, Middle East & Africa, Global, Europe, Asia Pacific, Africa, Middle East, China,
Description
Table of Content
Tables & Figures
China Alzheimer's Disease Drug Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (M Units)
China Alzheimer's Disease Drug Market Segment Percentages, By Type, 2020 (%)
Donepezil
Memantine
Rivastigmine
Others
China Alzheimer's Disease Drug Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (M Units)
China Alzheimer's Disease Drug Market Segment Percentages, By Application, 2020 (%)
Early to Moderate Stages
Moderate to Severe Stages
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Alzheimer's Disease Drug revenues in China market, 2016-2021 (Estimated), ($ millions)
Key companies Alzheimer's Disease Drug revenues share in China market, 2020 (%)
Key companies Alzheimer's Disease Drug sales in China market, 2016-2021 (Estimated), (M Units)
Key companies Alzheimer's Disease Drug sales share in China market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

Allergan
Eisai
Novartis
Daiichi Sankyo
Merz Pharma
Pfizer
Johnson & Johnson
Lundbeck
1 Introduction to Research & Analysis Reports
1.1 Alzheimer's Disease Drug Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Alzheimer's Disease Drug Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Alzheimer's Disease Drug Overall Market Size
2.1 China Alzheimer's Disease Drug Market Size: 2021 VS 2027
2.2 China Alzheimer's Disease Drug Revenue, Prospects & Forecasts: 2016-2027
2.3 China Alzheimer's Disease Drug Sales: 2016-2027
3 Company Landscape
3.1 Top Alzheimer's Disease Drug Players in China Market
3.2 Top China Alzheimer's Disease Drug Companies Ranked by Revenue
3.3 China Alzheimer's Disease Drug Revenue by Companies
3.4 China Alzheimer's Disease Drug Sales by Companies
3.5 China Alzheimer's Disease Drug Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Alzheimer's Disease Drug Companies in China Market, by Revenue in 2020
3.7 Manufacturers Alzheimer's Disease Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Alzheimer's Disease Drug Players in China Market
3.8.1 List of Tier 1 Alzheimer's Disease Drug Companies in China
3.8.2 List of Tier 2 and Tier 3 Alzheimer's Disease Drug Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Alzheimer's Disease Drug Market Size Markets, 2021 & 2027
4.1.2 Donepezil
4.1.3 Memantine
4.1.4 Rivastigmine
4.1.5 Others
4.2 By Type - China Alzheimer's Disease Drug Revenue & Forecasts
4.2.1 By Type - China Alzheimer's Disease Drug Revenue, 2016-2021
4.2.2 By Type - China Alzheimer's Disease Drug Revenue, 2022-2027
4.2.3 By Type - China Alzheimer's Disease Drug Revenue Market Share, 2016-2027
4.3 By Type - China Alzheimer's Disease Drug Sales & Forecasts
4.3.1 By Type - China Alzheimer's Disease Drug Sales, 2016-2021
4.3.2 By Type - China Alzheimer's Disease Drug Sales, 2022-2027
4.3.3 By Type - China Alzheimer's Disease Drug Sales Market Share, 2016-2027
4.4 By Type - China Alzheimer's Disease Drug Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Alzheimer's Disease Drug Market Size, 2021 & 2027
5.1.2 Early to Moderate Stages
5.1.3 Moderate to Severe Stages
5.2 By Application - China Alzheimer's Disease Drug Revenue & Forecasts
5.2.1 By Application - China Alzheimer's Disease Drug Revenue, 2016-2021
5.2.2 By Application - China Alzheimer's Disease Drug Revenue, 2022-2027
5.2.3 By Application - China Alzheimer's Disease Drug Revenue Market Share, 2016-2027
5.3 By Application - China Alzheimer's Disease Drug Sales & Forecasts
5.3.1 By Application - China Alzheimer's Disease Drug Sales, 2016-2021
5.3.2 By Application - China Alzheimer's Disease Drug Sales, 2022-2027
5.3.3 By Application - China Alzheimer's Disease Drug Sales Market Share, 2016-2027
5.4 By Application - China Alzheimer's Disease Drug Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Allergan
6.1.1 Allergan Corporation Information
6.1.2 Allergan Overview
6.1.3 Allergan Alzheimer's Disease Drug Sales and Revenue in China Market (2016-2021)
6.1.4 Allergan Alzheimer's Disease Drug Product Description
6.1.5 Allergan Recent Developments
6.2 Eisai
6.2.1 Eisai Corporation Information
6.2.2 Eisai Overview
6.2.3 Eisai Alzheimer's Disease Drug Sales and Revenue in China Market (2016-2021)
6.2.4 Eisai Alzheimer's Disease Drug Product Description
6.2.5 Eisai Recent Developments
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Overview
6.3.3 Novartis Alzheimer's Disease Drug Sales and Revenue in China Market (2016-2021)
6.3.4 Novartis Alzheimer's Disease Drug Product Description
6.3.5 Novartis Recent Developments
6.4 Daiichi Sankyo
6.4.1 Daiichi Sankyo Corporation Information
6.4.2 Daiichi Sankyo Overview
6.4.3 Daiichi Sankyo Alzheimer's Disease Drug Sales and Revenue in China Market (2016-2021)
6.4.4 Daiichi Sankyo Alzheimer's Disease Drug Product Description
6.4.5 Daiichi Sankyo Recent Developments
6.5 Merz Pharma
6.5.1 Merz Pharma Corporation Information
6.5.2 Merz Pharma Overview
6.5.3 Merz Pharma Alzheimer's Disease Drug Sales and Revenue in China Market (2016-2021)
6.5.4 Merz Pharma Alzheimer's Disease Drug Product Description
6.5.5 Merz Pharma Recent Developments
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Overview
6.6.3 Pfizer Alzheimer's Disease Drug Sales and Revenue in China Market (2016-2021)
6.6.4 Pfizer Alzheimer's Disease Drug Product Description
6.6.5 Pfizer Recent Developments
6.7 Johnson & Johnson
6.7.1 Johnson & Johnson Corporation Information
6.7.2 Johnson & Johnson Overview
6.7.3 Johnson & Johnson Alzheimer's Disease Drug Sales and Revenue in China Market (2016-2021)
6.7.4 Johnson & Johnson Alzheimer's Disease Drug Product Description
6.7.5 Johnson & Johnson Recent Developments
6.8 Lundbeck
6.8.1 Lundbeck Corporation Information
6.8.2 Lundbeck Overview
6.8.3 Lundbeck Alzheimer's Disease Drug Sales and Revenue in China Market (2016-2021)
6.8.4 Lundbeck Alzheimer's Disease Drug Product Description
6.8.5 Lundbeck Recent Developments
7 China Alzheimer's Disease Drug Production Capacity, Analysis
7.1 China Alzheimer's Disease Drug Production Capacity, 2016-2027
7.2 Alzheimer's Disease Drug Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Alzheimer's Disease Drug Supply Chain Analysis
9.1 Alzheimer's Disease Drug Industry Value Chain
9.2 Alzheimer's Disease Drug Upstream Market
9.3 Alzheimer's Disease Drug Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Alzheimer's Disease Drug Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
    Table 1. Key Players of Alzheimer's Disease Drug in China Market
    Table 2. Top Alzheimer's Disease Drug Players in China Market, Ranking by Revenue (2019)
    Table 3. China Alzheimer's Disease Drug Revenue by Companies, (US$, Mn), 2016-2021
    Table 4. China Alzheimer's Disease Drug Revenue Share by Companies, 2016-2021
    Table 5. China Alzheimer's Disease Drug Sales by Companies, (M Units), 2016-2021
    Table 6. China Alzheimer's Disease Drug Sales Share by Companies, 2016-2021
    Table 7. Key Manufacturers Alzheimer's Disease Drug Price (2016-2021) & (US$/Unit)
    Table 8. Manufacturers Alzheimer's Disease Drug Product Type
    Table 9. List of Tier 1 Alzheimer's Disease Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 10. List of Tier 2 and Tier 3 Alzheimer's Disease Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 11. Major Manufacturers of Donepezil
    Table 12. Major Manufacturers of Memantine
    Table 13. By Type – China Alzheimer's Disease Drug Revenue, (US$, Mn), 2021 & 2027
    Table 14. By Type - China Alzheimer's Disease Drug Revenue (US$, Mn), 2016-2021
    Table 15. By Type - China Alzheimer's Disease Drug Revenue (US$, Mn), 2022-2027
    Table 16. By Type - China Alzheimer's Disease Drug Sales (M Units), 2016-2021
    Table 17. By Type - China Alzheimer's Disease Drug Sales (M Units), 2022-2027
    Table 18. By Application – China Alzheimer's Disease Drug Revenue, (US$, Mn), 2021 VS 2027
    Table 19. By Application - China Alzheimer's Disease Drug Revenue (US$, Mn), 2016-2021
    Table 20. By Application - China Alzheimer's Disease Drug Revenue (US$, Mn), 2022-2027
    Table 21. By Application - China Alzheimer's Disease Drug Sales (M Units), 2016-2021
    Table 22. By Application - China Alzheimer's Disease Drug Sales (M Units), 2022-2027
    Table 23. Allergan Corporation Information
    Table 24. Allergan Description and Major Businesses
    Table 25. Allergan Alzheimer's Disease Drug Sales (M Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
    Table 26. Allergan Alzheimer's Disease Drug Product
    Table 27. Allergan Recent Developments
    Table 28. Eisai Corporation Information
    Table 29. Eisai Description and Major Businesses
    Table 30. Eisai Alzheimer's Disease Drug Sales (M Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
    Table 31. Eisai Alzheimer's Disease Drug Product
    Table 32. Eisai Recent Developments
    Table 33. Novartis Corporation Information
    Table 34. Novartis Description and Major Businesses
    Table 35. Novartis Alzheimer's Disease Drug Sales (M Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
    Table 36. Novartis Alzheimer's Disease Drug Product
    Table 37. Novartis Recent Developments
    Table 38. Daiichi Sankyo Corporation Information
    Table 39. Daiichi Sankyo Description and Major Businesses
    Table 40. Daiichi Sankyo Alzheimer's Disease Drug Sales (M Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
    Table 41. Daiichi Sankyo Alzheimer's Disease Drug Product
    Table 42. Daiichi Sankyo Recent Developments
    Table 43. Merz Pharma Corporation Information
    Table 44. Merz Pharma Description and Major Businesses
    Table 45. Merz Pharma Alzheimer's Disease Drug Sales (M Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
    Table 46. Merz Pharma Alzheimer's Disease Drug Product
    Table 47. Merz Pharma Recent Developments
    Table 48. Pfizer Corporation Information
    Table 49. Pfizer Description and Major Businesses
    Table 50. Pfizer Alzheimer's Disease Drug Sales (M Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
    Table 51. Pfizer Alzheimer's Disease Drug Product
    Table 52. Pfizer Recent Developments
    Table 53. Johnson & Johnson Corporation Information
    Table 54. Johnson & Johnson Description and Major Businesses
    Table 55. Johnson & Johnson Alzheimer's Disease Drug Sales (M Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
    Table 56. Johnson & Johnson Alzheimer's Disease Drug Product
    Table 57. Johnson & Johnson Recent Developments
    Table 58. Lundbeck Corporation Information
    Table 59. Lundbeck Description and Major Businesses
    Table 60. Lundbeck Alzheimer's Disease Drug Sales (M Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
    Table 61. Lundbeck Alzheimer's Disease Drug Product
    Table 62. Lundbeck Recent Developments
    Table 63. Alzheimer's Disease Drug Production Capacity (M Units) of Key Manufacturers in China Market, 2019-2021 (M Units)
    Table 64. China Alzheimer's Disease Drug Capacity Market Share of Key Manufacturers, 2019-2021
    Table 65. Alzheimer's Disease Drug Market Opportunities & Trends in China Market
    Table 66. Alzheimer's Disease Drug Market Drivers in China Market
    Table 67. Alzheimer's Disease Drug Market Restraints in China Market
    Table 68. Alzheimer's Disease Drug Raw Materials
    Table 69. Alzheimer's Disease Drug Raw Materials Suppliers in China Market
    Table 70. Typical Alzheimer's Disease Drug Downstream
    Table 71. Alzheimer's Disease Drug Downstream Clients in China Market
    Table 72. Alzheimer's Disease Drug Distributors and Sales Agents in China Market
List of Figures
    Figure 1. Alzheimer's Disease Drug Product Picture
    Figure 2. Alzheimer's Disease Drug Segment by Type
    Figure 3. Alzheimer's Disease Drug Segment by Application
    Figure 4. China Alzheimer's Disease Drug Market Overview: 2020
    Figure 5. China Alzheimer's Disease Drug Market Size: 2021 VS 2027 (US$, Mn)
    Figure 6. China Alzheimer's Disease Drug Revenue, 2016-2027 (US$, Mn)
    Figure 7. Alzheimer's Disease Drug Sales in China Market: 2016-2027 (M Units)
    Figure 8. The Top 3 and 5 Players Market Share by Alzheimer's Disease Drug Revenue in 2020
    Figure 9. Donepezil Product Picture
    Figure 10. Memantine Product Picture
    Figure 11. Rivastigmine Product Picture
    Figure 12. Others Product Picture
    Figure 13. By Type - China Alzheimer's Disease Drug Sales Market Share, 2016-2027
    Figure 14. By Type - China Alzheimer's Disease Drug Revenue Market Share, 2016-2027
    Figure 15. By Type - China Alzheimer's Disease Drug Price (US$/Unit), 2016-2027
    Figure 16. Early to Moderate Stages
    Figure 17. Moderate to Severe Stages
    Figure 18. By Application - China Alzheimer's Disease Drug Sales Market Share, 2016-2027
    Figure 19. By Application - China Alzheimer's Disease Drug Revenue Market Share, 2016-2027
    Figure 20. By Application - China Alzheimer's Disease Drug Price (US$/Unit), 2016-2027
    Figure 21. Allergan Alzheimer's Disease Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 22. Eisai Alzheimer's Disease Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 23. Novartis Alzheimer's Disease Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 24. Daiichi Sankyo Alzheimer's Disease Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 25. Merz Pharma Alzheimer's Disease Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 26. Pfizer Alzheimer's Disease Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 27. Johnson & Johnson Alzheimer's Disease Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 28. Lundbeck Alzheimer's Disease Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 29. China Alzheimer's Disease Drug Production Capacity (M Units), 2016-2027
    Figure 30. Alzheimer's Disease Drug Industry Value Chain
    Figure 31. Marketing Channels
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3400
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$5100
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$6800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano Dimension